PDCD1 and primary cutaneous T-cell non-Hodgkin lymphoma: This high level of expression of PD-1 is associated with CTCL progression as the level of expression of PD-1 and PD-L1 is higher in an advanced stage in comparison with better-managed CTCL (82, 103).